Tech Company Inital Public Offerings
NephroGenex IPO
NephroGenex, based in Raleigh, debuted as a public company on 2/11/2014.
Transaction Overview
Company Name
Announced On
2/11/2014
Transaction Type
IPO
Amount
$37,200,000
Proceeds Purpose
Proceeds purposes are on file with company statements at the SEC.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
3200 Beechleaf Ct. 900
Raleigh, NC 27604
USA
Raleigh, NC 27604
USA
Phone
Website
Email Address
Overview
NephroGenex (NASDAQ: NRX) is a biotechnology company applying the latest advances in molecular profiling technologies to unravel the complex pathologies found in kidney disease.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Peter Isdale
Browse more venture capital transactions:
Prev: 2/11/2014: Kaltura venture capital transaction
Next: 2/11/2014: Enumeral Biomedical venture capital transaction
Share this article
Where The Data Comes From
We do our best to record every notable VC transaction. VC investment data records reported here are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs